Nephrologists were less likely than rheumatologists to order serum uric acid testing in the year after patients with gout started urate-lowering therapy. Although monitoring of serum uric acid levels ...

Baseline serum metabolomic profiles may help predict gout flare risk at ULT initiation and identify patients less likely to respond adequately to colchicine prophylaxis.

Gout is a condition caused by the deposit of uric crystals in the joints, resulting in severe swelling and pain in various joints in the body. This disease mostly affects men between the ages of 30 ...

NEW ORLEANS — According to Mayoclinic.org, “gout is a common and complex form of arthritis that can affect anyone. It's characterized by sudden, severe attacks of pain, swelling, redness and ...

Please provide your email address to receive an email when new articles are posted on . SCOTTSDALE, Ariz. — Clinicians know that patients can vary widely by onset, location and serum uric acid levels, ...

Patients with asymptomatic hyperuricemia who achieved serum uric acid levels of 6.0 mg/dL or less while on urate-lowering therapy had fewer gout flare episodes, a study found. Controlling asymptomatic ...

The researchers of the TICOG study compared conventional management of gout with monthly ULT titration in achieving and maintaining SUA at a target level of 0.30mmol/L or lesser. In patients with gout ...

Extreme values of serum uric acid levels in the blood can markedly reduce a patient's chance of surviving and reduce their lifespans by up to 11 years, according to a new study by researchers at ...

PHENYLBUTAZONE (3, 5-dioxo-l, 2–diphenyl4-n-butyl-pyrazolidin sodium) is a pyrazolon derivative with anti-inflammatory and analgesic properties. 1 Its formula is as follows: Patients with acute ...